Renzapride (ATL-1251): Began Phase II trial

Alizyme plc (LSE:AZM), Cambridge, U.K. Product: Renzapride (ATL-1251) Business: Autoimmune/Inflammation Therapeutic category: Neurotransmission Target: 5-HT serotonin receptors Description: 5-HT4 rece...